ConductScience.org, home

Paper41585441

Targeting IBD treatment: smart drug delivery systems for oral administration.

Xu J and 6 others. Mater Today Bio, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Targeting IBD treatment: smart drug delivery systems for oral administration. Papers, record 41585441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting IBD treatment: smart drug delivery systems for oral administration.
PubMed
Journal
Mater Today Bio
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-01-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu JJiabin
2Tang PPeiyu
3Sun XXiaoyi
4Song YYihan
5Lin KKaili
6Jiang SShan
7Yuan CChangyong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References206

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124184170Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.J Crohns Colitis2014https://conductscience.org/library/papers/24184170PubMed
235286854An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome.Biomaterials2022https://conductscience.org/library/papers/35286854PubMed
335863523SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.Gastroenterology2022https://conductscience.org/library/papers/35863523PubMed
425543006Non-genetic engineering of cells for drug delivery and cell-based therapy.Adv Drug Deliv Rev2015https://conductscience.org/library/papers/25543006PubMed
534635910ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.J Crohns Colitis2022https://conductscience.org/library/papers/34635910PubMed
635285362Dual-targeted colon-based integrated micelle drug delivery system for treatment of ulcerative colitis.J Drug Target2022https://conductscience.org/library/papers/35285362PubMed
735101421What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?Gastroenterology2022https://conductscience.org/library/papers/35101421PubMed
811768558The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.Scand J Gastroenterol Suppl2001https://conductscience.org/library/papers/11768558PubMed
935973472In situ hydrogel capturing nitric oxide microbubbles accelerates the healing of diabetic foot.J Control Release2022https://conductscience.org/library/papers/35973472PubMed
1039633585Advances in colon-targeted drug technologies.Curr Opin Gastroenterol2025https://conductscience.org/library/papers/39633585PubMed
1136958817Faecal metabolome and its determinants in inflammatory bowel disease.Gut2023https://conductscience.org/library/papers/36958817PubMed
1228088460Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.Gastroenterology2017https://conductscience.org/library/papers/28088460PubMed
1335595052Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis.Autoimmun Rev2022https://conductscience.org/library/papers/35595052PubMed
1436976334Comprehensive Analysis of the Physiological Characterization of Escherichia coli Nissle 1917.Curr Microbiol2023https://conductscience.org/library/papers/36976334PubMed
1519348015pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.Eur J Pharm Biopharm2009https://conductscience.org/library/papers/19348015PubMed
1637651187Theranostic gold-in-gold cage nanoparticles enable photothermal ablation and photoacoustic imaging in biofilm-associated infection models.J Clin Invest2023https://conductscience.org/library/papers/37651187PubMed
1729872293Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.Int J Nanomedicine2018https://conductscience.org/library/papers/29872293PubMed
1837733924Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice.ACS Biomater Sci Eng2023https://conductscience.org/library/papers/37733924PubMed
1920393175Infliximab, azathioprine, or combination therapy for Crohn's disease.N Engl J Med2010https://conductscience.org/library/papers/20393175PubMed
2033107344Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia.Expert Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33107344PubMed

See all 206 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42890836Release and Targeting Mechanism of Nanomedicine Delivery System in Inflammatory Bowel Disease.Int J Nanomedicine2026https://conductscience.org/library/papers/42890836PubMed
42856478Microbiome-aware oral drug delivery: excipient-microbiome interactions and nanocarrier design rules for predictable formulation performance.Front Pharmacol2026https://conductscience.org/library/papers/42856478PubMed
42806247Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract.Pharm Res2026https://conductscience.org/library/papers/42806247PubMed
42388373Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design.Mater Today Bio2026https://conductscience.org/library/papers/42388373PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41585441

GET https://conductscience.org/api/papers/v1/41585441/references?page=2